70 related articles for article (PubMed ID: 21784112)
1. Interplay of salicylaldehyde, lysine, and M2+ ions on α-synuclein aggregation: cancellation of aggregation effects and determination of salicylaldehyde neurotoxicity.
Ha Y; Liew H; Park HY; Kim K; Suh YH; Churchill DG
Neurosci Res; 2011 Oct; 71(2):168-77. PubMed ID: 21784112
[TBL] [Abstract][Full Text] [Related]
2. Redox activity of α-synuclein-Cu is silenced by Zn₇-metallothionein-3.
Meloni G; Vašák M
Free Radic Biol Med; 2011 Jun; 50(11):1471-9. PubMed ID: 21320589
[TBL] [Abstract][Full Text] [Related]
3. Facile "stop codon" method reveals elevated neuronal toxicity by discrete S87p-α-synuclein oligomers.
Ha Y; Yang A; Lee S; Kim K; Liew H; Suh YH; Park HS; Churchill DG
Biochem Biophys Res Commun; 2014 Jan; 443(3):1085-91. PubMed ID: 24380864
[TBL] [Abstract][Full Text] [Related]
4. Copper binding regulates intracellular alpha-synuclein localisation, aggregation and toxicity.
Wang X; Moualla D; Wright JA; Brown DR
J Neurochem; 2010 May; 113(3):704-14. PubMed ID: 20141569
[TBL] [Abstract][Full Text] [Related]
5. Baicalein inhibits formation of α-synuclein oligomers within living cells and prevents Aβ peptide fibrillation and oligomerisation.
Lu JH; Ardah MT; Durairajan SS; Liu LF; Xie LX; Fong WF; Hasan MY; Huang JD; El-Agnaf OM; Li M
Chembiochem; 2011 Mar; 12(4):615-24. PubMed ID: 21271629
[TBL] [Abstract][Full Text] [Related]
6. Dual effects of alpha-synuclein on neurotoxicity induced by low dosage of rotenone are dependent on exposure time in dopaminergic neuroblastoma cells.
Lu L; Gu L; Liang Y; Sun X; Duan C; Yang H
Sci China Life Sci; 2010 May; 53(5):590-7. PubMed ID: 20596942
[TBL] [Abstract][Full Text] [Related]
7. alpha-Synuclein overexpression during manganese-induced apoptosis in SH-SY5Y neuroblastoma cells.
Li Y; Sun L; Cai T; Zhang Y; Lv S; Wang Y; Ye L
Brain Res Bull; 2010 Mar; 81(4-5):428-33. PubMed ID: 19932157
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection of α-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson's disease mutations A30P, A53T and E46K.
Choong CJ; Say YH
Neurotoxicology; 2011 Dec; 32(6):857-63. PubMed ID: 21658409
[TBL] [Abstract][Full Text] [Related]
9. [Overexpression of alpha-synuclein in SH-SY5Y cells partially protected against oxidative stress induced by rotenone].
Liu YY; Zhao HY; Zhao CL; Duan CL; Lu LL; Yang H
Sheng Li Xue Bao; 2006 Oct; 58(5):421-8. PubMed ID: 17041725
[TBL] [Abstract][Full Text] [Related]
10. Raised calcium and oxidative stress cooperatively promote alpha-synuclein aggregate formation.
Goodwin J; Nath S; Engelborghs Y; Pountney DL
Neurochem Int; 2013 Apr; 62(5):703-11. PubMed ID: 23159813
[TBL] [Abstract][Full Text] [Related]
11. Thioredoxin-albumin fusion protein prevents copper enhanced zinc-induced neurotoxicity via its antioxidative activity.
Tanaka KI; Shimoda M; Chuang VTG; Nishida K; Kawahara M; Ishida T; Otagiri M; Maruyama T; Ishima Y
Int J Pharm; 2018 Jan; 535(1-2):140-147. PubMed ID: 29122608
[TBL] [Abstract][Full Text] [Related]
12. Differential copper binding to alpha-synuclein and its disease-associated mutants affect the aggregation and amyloid formation.
Ranjan P; Ghosh D; Yarramala DS; Das S; Maji SK; Kumar A
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):365-374. PubMed ID: 27916677
[TBL] [Abstract][Full Text] [Related]
13. Impairment of microtubule system increases alpha-synuclein aggregation and toxicity.
Kim M; Jung W; Lee IH; Bhak G; Paik SR; Hahn JS
Biochem Biophys Res Commun; 2008 Jan; 365(4):628-35. PubMed ID: 18022384
[TBL] [Abstract][Full Text] [Related]
14. Effects of the cholesterol-lowering compound methyl-beta-cyclodextrin in models of alpha-synucleinopathy.
Bar-On P; Rockenstein E; Adame A; Ho G; Hashimoto M; Masliah E
J Neurochem; 2006 Aug; 98(4):1032-45. PubMed ID: 16895578
[TBL] [Abstract][Full Text] [Related]
15. Understanding the Inhibitory and Antioxidant Effects of Pyrroloquinoline Quinone (PQQ) on Copper(II)-Induced α-Synuclein-119 Aggregation.
Li S; Raja A; Noroozifar M; Kerman K
ACS Chem Neurosci; 2022 Apr; 13(8):1178-1186. PubMed ID: 35413176
[TBL] [Abstract][Full Text] [Related]
16. Binding of neuronal α-synuclein to β-III tubulin and accumulation in a model of multiple system atrophy.
Nakayama K; Suzuki Y; Yazawa I
Biochem Biophys Res Commun; 2012 Jan; 417(4):1170-5. PubMed ID: 22227187
[TBL] [Abstract][Full Text] [Related]
17. Alpha-synuclein knockdown attenuates MPP+ induced mitochondrial dysfunction of SH-SY5Y cells.
Wu F; Poon WS; Lu G; Wang A; Meng H; Feng L; Li Z; Liu S
Brain Res; 2009 Oct; 1292():173-9. PubMed ID: 19646423
[TBL] [Abstract][Full Text] [Related]
18. Ribosylation rapidly induces alpha-synuclein to form highly cytotoxic molten globules of advanced glycation end products.
Chen L; Wei Y; Wang X; He R
PLoS One; 2010 Feb; 5(2):e9052. PubMed ID: 20140223
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of the norepinephrine transporter activity and trafficking via interactions with alpha-synuclein.
Wersinger C; Jeannotte A; Sidhu A
Eur J Neurosci; 2006 Dec; 24(11):3141-52. PubMed ID: 17156375
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of TAT-delivered alpha-synuclein: relevance of the C-terminal domain and involvement of HSP70.
Albani D; Peverelli E; Rametta R; Batelli S; Veschini L; Negro A; Forloni G
FASEB J; 2004 Nov; 18(14):1713-5. PubMed ID: 15345691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
